Press releaseBusiness Wire
Ellington Credit
EARN · NYSE
$3.56+$0.04 (+1.14%)TodayMarket closed ·
Prev close $3.52
About EARN
- Employees
- 160
- Headquarters
- Old Greenwich, Connecticut
- Listed
- Jan 5, 2013
- Sector
- Financials
- Industry
- Capital Markets
- Website
- ellingtoncredit.com
EARN key statistics
- Market cap
- 168.37M
- Price-earnings ratio
- 0.00
- Dividend yield
- 23.86%
- Average volume
- 504.78K
- Volume
- 307.19K
- Open price
- $3.51
- High today
- $3.67
- Low today
- $3.51
- 52 Week high
- $5.72
- 52 Week low
- $3.22
Ellington Credit (EARN) at a glance
As of Oct 20, 2026, Ellington Credit (EARN) shares are priced at $3.56, giving the company a market cap of 168.37M, a price-to-earnings ratio of 0.00 and a dividend yield of 23.86%.
Today the stock has traded between $3.51 and $3.67. The current price is 1.4% above the day's low and 3.0% below its high.
Volume so far is 307.19K shares, below the average of 504.78K shares a day.
Over the past year Ellington Credit has ranged from $3.22 to $5.72, and now sits 14% of the way up that range.
Ellington Credit met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q1 FY26 it reported $0.19 per share against an estimate of $0.2448.
The average analyst price target is $5.10, 43.3% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 1 analyst rating say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 3 analystsAvg $5.10
- Low
- $5.05
- Now
- $3.56
- High
- $5.25
EARN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 15.3% on average.
- Q1 FY24: reported $0.27 per share against an estimate of $0.253
- Q2 FY24: reported $0.36 per share against an estimate of $0.2907
- Q3 FY24: reported $0.28 per share against an estimate of $0.2856
- Q4 FY24: reported $0.27 per share against an estimate of $0.306
- Q1 FY25: reported $0.26 per share against an estimate of $0.2729
- Q2 FY25: reported $0.18 per share against an estimate of $0.2346
- Q4 FY25: reported $0.21 per share against an estimate of $0.2448
- Q1 FY26: reported $0.19 per share against an estimate of $0.2448
EARN news
- Press releaseBusiness Wire
Ellington Credit Declares Monthly Common Distribution
- Press releaseBusiness Wire
Ellington Credit Company Announces Financial Results for the First Fiscal Quarter Ended June 30, 2026
- Press releaseBusiness Wire
Ellington Credit Declares Monthly Common Distribution
- Press releaseBusiness Wire
Ellington Credit Company Announces Release Date of Earnings, Conference Call, and Investor Presentation
- Press releaseBusiness Wire
Ellington Credit Declares Monthly Common Dividend
- Press releaseBusiness Wire
Ellington Credit Declares Monthly Common Dividend
- Press releaseBusiness Wire
Ellington Credit Company Announces Financial Results for the Fourth Fiscal Quarter Ended March 31, 2026
Similar companies
Companies in the same industry as Ellington Credit
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.